Merck has become inexpensive again and combines a good growth outlook with a nice and growing dividend. Learn why MRK stock ...

(RTTNews) - Merck & Co Inc. (MRK), Monday said China's National Medical Products Administration (NMPA) has approved Keytruda in combination with chemo therapy as neoadjuvant treatment, then as ...

Merck & Co – known as MSD outside of the US and Canada – has shared positive results from a late-stage trial of a Keytruda ...

New research revealed tumor mutational burden was linked to improved event-free survival with pembrolizumab in early TNBC, ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at ...

Altimmune is redefining success in both obesity and MASH to position Pemvidutide in blue ocean categories. Read why I rate ...

As a new legislative session is set to start in January, Gov. Kathy Hochul is focused on proposals to alleviate costs for ...

When managing complex chronic dermatologic diseases, efforts to incorporate alternative treatments can add efficacy, patient ...

Pharmaceutical Suspension Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033. The Business Research Company's Early Year-End Sa ...

APSA-02 is a biologic commercialized by Armata Pharmaceuticals, with a leading Phase II program in Bacteremia.

Evaluate the competition with an in-depth report: What Key Players Are Driving the Pharmaceutical Water Market? The pharmaceutical water market's growth is spurred on by key players including Merck & ...